Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

T J Creed; M R Norman; C S J Probert; R F Harvey; I S Shaw; J Smithson; J Anderson; M Moorghen; J Gupta; N A Shepherd

doi:10.1046/j.1365-2036.2003.01639.x

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

Identifier:nobleid.org/w1/20260515/0853CEBC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0853CEBC.svg?ark=w1%2F20260515%2F0853CEBC)](https://nobleid.org/work/w1/20260515/0853CEBC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

Identifier:nobleid.org/w1/20260515/0853CEBC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0853CEBC.svg?ark=w1%2F20260515%2F0853CEBC)](https://nobleid.org/work/w1/20260515/0853CEBC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work